MARKSANS PHARMA
|
The Current P/S Ratio of MARKSANS PHARMA is 3.71.
Share Price | ₹172.2 | Apr 26,2024 |
Market Cap | ₹7,804.1 Cr | |
Sales-TTM | ₹2,103.4 Cr | TTM-Consolidated Results |
Price/Sales | 3.71x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of MARKSANS PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹7,804.1 Cr] as on Apr 26,2024
(/) Sales [ ₹2,103.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.71x ]
Thus, for MARKSANS PHARMA , the investors are currently willing to pay '3.71 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of MARKSANS PHARMA !
The chart below summarizes the trend in P/S Ratio of MARKSANS PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of MARKSANS PHARMA
PS Ratio Performance Analysis for MARKSANS PHARMA
- MARKSANS PHARMA 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 1.20x.
- MARKSANS PHARMA 's operated at median p/e ratio of 1.25x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MARKSANS PHARMA 's p/e ratio peaked in Mar2023 at 1.72x.
- MARKSANS PHARMA 's p/e ratio hit its five-year low in Mar2020 of 0.5x.
How does MARKSANS PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
MARKSANS PHARMA | 2,103.4 | 3.71 | 7,804.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 47,444.6 | 7.61 | 360,920.0 |
CIPLA LTD | 25,350.2 | 4.49 | 113,794.0 |
DR REDDYS LABORATORIES LTD | 27,212.5 | 3.83 | 104,316.0 |
ZYDUS LIFESCIENCES LTD | 19,024.2 | 5.01 | 95,380.9 |
DIVIS LABORATORIES LTD | 7,492.8 | 14.26 | 106,860.0 |
MANKIND PHARMA LTD | 9,946.3 | 9.54 | 94,869.4 |
TORRENT PHARMACEUTICALS LTD | 10,474.0 | 8.69 | 91,057.0 |
LUPIN LTD | 19,480.1 | 3.78 | 73,642.4 |
AUROBINDO PHARMA LTD | 27,894.7 | 2.38 | 66,278.5 |
ABBOTT INDIA LTD | 5,753.4 | 9.55 | 54,961.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs MARKSANS PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.38x |
Max industry PS | 14.26x |
Median industry PS | 5.01x |
Average industry PS | 6.62x |
You may also like the below Video Courses